New Changes in Medical Supplies of Ambulance Teams Will Enter into Force on July 1, 2016

The RF Ministry of Health by its Order No.36n, dated January 22, 2016, approved the requirements for medicines and medical products supplied to complete kits and sets for emergency medical aid. According to the Order, active substance bromdihydrochlorphenylbenzodiazepine Phenazepam® supplied in the form of tablets for oral application and in the form of solutions for intravenous and intramuscular injections is included in the list of mandatory equipment of ambulance teams. The document will enter into force on July 1, 2016.

Phenazepam® is one of key medicines in neuropsychological portfolio of Valenta. Healthcare professionals of different profiles highly appreciate the medicine. One of its developers, Director of Zakusov Scientific and Research Institute of Pharmacology, Academician Sergey Borisovich Seredenin, in his interview to portal «Scientific Russia»¹ with in the topic «Development of new medicines: challenges and limitations» highly appreciated the doctors’ adherence to this medicine, which confirms the demand for it and the urgency of its application for treatment of various diseases today.

Sergey Borisovich Seredenin, Academician of RAS and RAMS, Doctor of Medicine, Professor, Director of Scientific and Research Institute of Pharmacology named after V.V. Zakusov. In 1969, he graduated from the 2^nd Moscow Medical Institute named after N.I. Pirogov. In 1972, he was granted the degree of Candidate of Medicine, in 1983 – the MD degree. He made his career from Scientific Researcher and then Lecturer at the Department of Molecular Pharmacology and Radiobiology to Head of Pharmacogenetics Laboratory of the 2^nd MMI named after N.I. Pirogov. In 1991, S.B. Seredenin was appointed the Director of the Scientific and Research Institute of Pharmacology of the Russian Academy of Medical Science (SE Scientific and Research Institute of Pharmacology named after V.V. Zakusov, RAMS). The sphere of scientific interests: pharmacology and pharmacogenetics. S.B. Seredenin has developed and studied anxiolytics (Phenazepam®), nootropics, and antiasthenics. He is the author of about 300 scientific works and five monographs.

About Phenazepam®

Russian originator medicine producing anxiolytic, sedative, anticonvulsive and central myorelaxant effects. Phenazepam® is applied for neurotic, neurosis-like psychopathic, psychopathic-like and other conditions, accompanied by anxiety, fear, increased irritability, tenseness, and emotional lability. It is also prescribed for reactive psychoses, senestopathic hypochondria syndrome, vegetative dysfunctions and sleeping disorders, for preventive maintenance of phobias and emotional stresses. The medicine has been successfully used for more than 30 years in psychiatry, general therapy, neurology and cardiology.

• ¹http://scientificrussia.ru/articles/sozdanie-novyh-lekarstv-vyzovy-i-ogranicheniya